CoChat

Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance

Open access
Davidowitz, Rachel A., Selfors, Laura M., Iwanicki, Marcin P., Elias, Kevin M., Karst, Alison, Piao, Huiying, Ince, Tan A., Drage, Michael G., Dering, Judy, Konecny, Gottfried E., Matulonis, Ursula, Mills, Gordon B., Slamon, Dennis J., Drapkin, Ronny, Brugge, Joan S. · 2014 · Journal of Clinical Investigation
Cited by 131

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used an in vitro assay that models the initial step of ovarian cancer metastasis, clearance of the mesothelial cell layer, to examine the clearance ability of a large panel of both established and primary ovarian tumor cells. Comparison of the gene and protein expression profiles of clearance-competent and clearance-incompetent cells revealed that mesenchymal genes are enriched in tumor populations that display strong clearance activity, while epithelial genes are enriched in those with weak or undetectable activity. Overexpression of transcription factors SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mesothelial clearance in cell lines with weak activity, while knockdown of the EMT-regulatory transcription factors TWIST1 and ZEB1 attenuated mesothelial clearance in ovarian cancer cell lines with strong activity. These findings provide important insights into the mechanisms associated with metastatic progression of ovarian cancer and suggest that inhibiting pathways that drive mesenchymal programs may suppress tumor cell invasion of peritoneal tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci69815

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 131

Metadata

Authors
Davidowitz, R. A., Selfors, L. M., Iwanicki, M. P., Elias, K. M., Karst, A., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., Matulonis, U., Mills, G. B., Slamon, D. J., Drapkin, R., & Brugge, J. S.
Venue
Journal of Clinical Investigation
Published
2014-04-24
Volume
124
Issue
6
Pages
2611-2625
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2147017973
Cited by
131
References
8
FWCI
5.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. https://app.cochat.ai/papers/10.1172/jci69815
The paper
Davidowitz, R. A., Selfors, L. M., Iwanicki, M. P., Elias, K. M., Karst, A., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., Matulonis, U., Mills, G. B., Slamon, D. J., Drapkin, R., & Brugge, J. S. (2014). Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. Journal of Clinical Investigation. https://doi.org/10.1172/jci69815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.